Changes in US stocks | Fast diet drug data sparks stock price, Viking Therapeutics (VKTX.US) soars by more than 30%

Zhitongcaijing · 1d ago

The Zhitong Finance App learned that on Tuesday, Viking Therapeutics (VKTX.US) went high and surged by more than 30% as of press release. According to the news, the biotech company announced that its experimental obesity drug VK2735 helped patients maintain most of their weight loss results even when the frequency of use was reduced from once a week to once every two weeks. This result is expected to further strengthen VK2735's competitive position in the rapidly expanding diet medicine market. VK2735 is seen as a potential competitor for major weight loss drugs such as Eli Lilly Zepbound and Novo Nordisk Wegovy.